 |
|
 |
| |
 |
|
Class Information
Number: 514/811
Name: Drug, bio-affecting and body treating compositions > Addiction > Alcohol
Description: Subject matter wherein the addictive substance is alcohol.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7402591 |
Analgesic compositions containing buprenorphine |
Jul. 22, 2008 |
| 7255882 |
Enkephalinase inhibitor and GABA precursor loading as anti-anxiety compositions |
Aug. 14, 2007 |
| 7108871 |
Methods of treatment using a soya extract |
Sep. 19, 2006 |
| 7074833 |
Use of the (1S,2R) enantiomer of milnacipran for the preparation of a drug |
Jul. 11, 2006 |
| 7005452 |
Use of the dextrogyral enantiomer of milnacipran for the preparation of a drug |
Feb. 28, 2006 |
| 6995169 |
Analgesic compositions containing buprenorphine |
Feb. 7, 2006 |
| 6828349 |
Treatment of addiction and addiction-related behavior |
Dec. 7, 2004 |
| 6627631 |
Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism |
Sep. 30, 2003 |
| 6617361 |
Behavior chemotherapy |
Sep. 9, 2003 |
| 6608064 |
Pharmaceutical agents for the treatment of Parkinson's disease, ADHD and microadenomas |
Aug. 19, 2003 |
| 6593367 |
Treatment of addiction and addiction-related behavior |
Jul. 15, 2003 |
| 6541520 |
Treatment of addiction and addiction-related behavior |
Apr. 1, 2003 |
| 6503950 |
Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms |
Jan. 7, 2003 |
| 6495155 |
Injectable opioid partial agonist or opioid antagonist microparticle compositions and their use in reducing consumption of abused substances |
Dec. 17, 2002 |
| 6492369 |
Therapeutic agents for drug dependence |
Dec. 10, 2002 |
| 6352984 |
Olanzapine-N-oxide compositions and methods |
Mar. 5, 2002 |
| 6333357 |
Behavior chemotherapy |
Dec. 25, 2001 |
| 6306425 |
Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol |
Oct. 23, 2001 |
| 6288047 |
Lipid-based immune modulator composition |
Sep. 11, 2001 |
| 6245360 |
Nutritional supplement |
Jun. 12, 2001 |
| 6204284 |
Use of 1-(substitutedphenyl)-3-azabicyclo[3.1.0]hexanes for the treatment of chemical dependencies |
Mar. 20, 2001 |
| 6197827 |
Nicotine addiction treatment |
Mar. 6, 2001 |
| 6159963 |
Method for treating substance abuse |
Dec. 12, 2000 |
| 6120806 |
Oral formulations for controlled release of alcohol deterrents |
Sep. 19, 2000 |
| 6121259 |
Olanzapine-N-oxide compositions and methods |
Sep. 19, 2000 |
| 6068981 |
Marking of orally ingested products |
May. 30, 2000 |
| 6051564 |
Phosphatidic acid-comprising compositions |
Apr. 18, 2000 |
| RE36547 |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists |
Feb. 1, 2000 |
| 6017884 |
Method for treating acute hepatic failure |
Jan. 25, 2000 |
| 6001848 |
Bromocriptine for the treatment of alcoholics diagnosed with the D.sub.2 dopamine receptor DRD2 A1 allele |
Dec. 14, 1999 |
| 5958962 |
Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence |
Sep. 28, 1999 |
| 5935980 |
Use of pyrrolidine derivatives in the treatment of alcoholism |
Aug. 10, 1999 |
| 5925680 |
Synthetic excitatory amino acids |
Jul. 20, 1999 |
| 5919781 |
Use of NK-1 receptor antogonists for treating substance use disorders |
Jul. 6, 1999 |
| 5902823 |
Method for treating addiction using forskolin or extracts containing forskolin |
May. 11, 1999 |
| 5888532 |
Treatment of alcoholism and related disorders with (nicotinamide-adenine dinucleotide) phosphate derivatives |
Mar. 30, 1999 |
| 5886028 |
Method for the inhibition of ALDH-I useful in the treatment of alcohol dependence or alcohol abuse |
Mar. 23, 1999 |
| 5882671 |
Anxiolytic agents |
Mar. 16, 1999 |
| 5834477 |
Opiate analgesic formulation with improved safety |
Nov. 10, 1998 |
| 5824684 |
Method for treating drug and alcohol addiction |
Oct. 20, 1998 |
| 5816260 |
Method for treating substance abuse withdrawal |
Oct. 6, 1998 |
| 5801171 |
Use of 3, 5-diamino-6-(2,3-dichlorophenyl)-1, 2, 4-triazine isethionate for the treatment and prevention of dependence; tolerance and sensitization of drugs |
Sep. 1, 1998 |
| 5798371 |
Pharmaceutical composition endowed with an antialcoholic and nootropic effect |
Aug. 25, 1998 |
| 5783189 |
Method for treating alcohol dependence |
Jul. 21, 1998 |
| 5780051 |
Methods and articles of manufacture for nicotine cessation and monitoring nicotine use |
Jul. 14, 1998 |
| 5767125 |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists |
Jun. 16, 1998 |
| 5732717 |
Method for treating substance abuse withdrawal |
Mar. 31, 1998 |
| 5668117 |
Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments |
Sep. 16, 1997 |
| 5661184 |
Psychiatric agents |
Aug. 26, 1997 |
| 5624910 |
Method for the inhibition of ALDH-I useful in the treatment of alcohol dependence or alcohol abuse |
Apr. 29, 1997 |
|
|
|
 |
|
 |
|
| |
Randomly Featured Patents |
|
